Helix Acquisition Corp II

-

Stock Issuer and Owners

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Helix Acquisition Corp II
TickerBBOT
CIK #0001869105
CUSIP107924102
SectorReal Estate & Construction - Blank Checks
Addressc/o Cormorant Asset Management, LP 200 Clarendon Street, 52Nd Floor, Boston, MA 02116
Source [EDGAR]
CIK Filing 2011 - 2026
[0001869105] 10-K
[0001869105] 10-Q
[0001869105] 3
[0001869105] 4
[0001869105] 8-K
[0001869105] SC 13D
[0001869105] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Bridgebio Pharma LLC Bridgebio Oncology Therapeutics Inc [2025-08-18] 0.0
Flynn James E Bridgebio Oncology Therapeutics Inc [2025-08-18] 0.0
Sculptor Capital LP Helix Acquisition Corp II [2025-07-24] 0.0
BlackRock Portfolio Management LLC Helix Acquisition Corp II [2025-04-15] 0.0
Price T Rowe Associates Inc /MD/ Helix Acquisition Corp II [2024-11-14] 6.0
BlackRock Inc Helix Acquisition Corp II [2024-11-08] 7.9
BlackRock Inc Helix Acquisition Corp II [2024-10-22] 7.9
Citadel Advisors LLC Helix Acquisition Corp II [2024-02-23] 7.0
Adage Capital Partners GP LLC Helix Acquisition Corp II [2024-02-23] 7.4
Helix Holdings II LLC Helix Acquisition Corp II [2024-02-20] 21.4
Integrated Core Strategies US LLC Helix Acquisition Corp II [2024-02-15] 5.0
Form 3/4/5 Filer 2011 - 2026
BridgeBio Oncology Therapeutics Inc
Beltran Pedro
Ben Yong
Elmelech Idan
Cobo Marc
Chen Bihua
Kelleher Raymond J
Lebowitz Peter F
McCormick Frank
Tipirneni Praveen P
Kumar Neil
Bauer Jake
Mehra Uneek
Wallace Eli M
BridgeBio Pharma LLC
BridgeBio Pharma LLC
DOIG Michelle
Schmid John P
McKenna Mark C
Holman Albert A III
Tripp Caleb
Obradovic Nebojsa
Helix Holdings II LLC
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Lebowitz Peter F
Stock Option (Right to Buy) · derivative
2026-03-24 Grant 63,350 $0.00
Mehra Uneek
Common Stock
2026-03-10 Grant 23,330 $0.00
Ben Yong
Common Stock
2026-03-10 Grant 46,670 $0.00
Mehra Uneek
Stock Option (Right to Buy) · derivative
2026-03-10 Grant 105,000 $0.00
Beltran Pedro
Common Stock
2026-03-10 Grant 46,670 $0.00
Ben Yong
Stock Option (Right to Buy) · derivative
2026-03-10 Grant 210,000 $0.00
Beltran Pedro
Stock Option (Right to Buy) · derivative
2026-03-10 Grant 210,000 $0.00
Wallace Eli M
Stock Option (Right to Buy) · derivative
2026-01-01 Grant 1,114,400 $0.00
Wallace Eli M
Stock Option (Right to Buy) · derivative
2025-12-10 Disposed to issuer 1,114,400
BridgeBio Pharma LLC +1
Common Stock
2025-10-10 Other 784,720
Wallace Eli M
Stock Option (Right to Buy) · derivative
2025-10-02 Grant 1,614,400 $0.00
Stock Option (Right to Buy) · derivative
2025-08-26 Grant 499,731 $0.00
Stock Option (Right to Buy) · derivative
2025-08-26 Grant 357,177 $0.00
Stock Option (Right to Buy) · derivative
2025-08-26 Grant 357,177 $0.00
Stock Option (Right to Buy) · derivative
2025-08-26 Grant 633,570 $0.00
Stock Option (Right to Buy) · derivative
2025-08-26 Grant 91,076 $0.00
Stock Option (Right to Buy) · derivative
2025-08-26 Grant 52,269 $0.00
Stock Option (Right to Buy) · derivative
2025-08-26 Grant 138,193 $0.00
McKenna Mark C
Common Stock
2025-08-11 Option exercise 30,000
Chen Bihua
Common Stock
2025-08-11 Disposed to issuer 152,940 $0.00
showing 20 of 41 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 67 57,479,041
2025-12-31 53 57,505,429
2025-09-30 42 55,928,222
Form 13F Holdings
Firm Period DFND Voting Shares
TEMA ETFS LLC [2026-06-30] SOLE 93,339 93,339
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com